packageOmalizumab

omalizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Omalizumab, a monoclonal antibody, is used to treat allergic conditions such as asthma and chronic urticaria. It is authorised in the European Union for asthma, urticaria, and rhinitis, and is used in clinical practice for these allergic airway and skin conditions.

Summary written by glm-5.3-flash from Wikidata Q415392 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:omalizumab
ATC codes:R03DX05
DrugBank:DB00043
Wikidata:Q415392
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown